Objective: To investigate the clinical effect of Lianhua Qingwen capsule in treatment of influenza combined with bronchial pneumonia. Method: From February 2010 to February 2013

the patients with bronchial pneumonia were randomly divided into treatment group and control group. The control group was treated with ribavirin

cefuroxime and other drug treatment

while patients in the treatment group were treated with Lianhua Qingwen capsule on the basis of the above treatment. The clinical effect and adverse reaction were compared between the two groups. Result: In this study

two groups of patients after 2 weeks of active treatment

in thetreatment group 13 cases were cured

16 cases markedly effective

the total effective rate was 90.63%;in the control group patients 10 cases recovered

12 cases markedly effective

the total effective rate was 68.75%;the statistical analysis found that in the treatment group the total efficiency was significantly higher than the control group(P<0.05).In the treatment group the the duration of clinical symptoms like fever

cough

shortness of breath was significantly shorter than the control group(P<0.05). The patients in the two groups during treatment had no hearing loss

acute kidney damage;1 patient in the treatment group had gastrointestinal discomfort

while patients in the control group had no adverse reactions

the statistical analysis of the incidence of adverse reaction showed no significant difference compared to control group. Conclusion: Lianhua Qingwen capsule has obvious anti-inflammatory against influenza virusin the treatment of influenza and pneumonia

and the safety is good.